Nektar Therapeutics Inc. (NKTR) Price Performance: A Comparative Analysis with Competitors
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 57.52%.However, over the last six months, we can see a weaker performance of 36.92%. Over the last 30 days, the price of NKTR has fallen by 25.35%. And in the last five days, it has surged by 0.67%. The market performance of Nektar Therapeutics’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.25 on